×
ADVERTISEMENT

enasidenib

FDA Approves Idhifa and RealTime IDH2 Assay for Relapsed or Refractory AML

Celgene's Idhifa was approved to treat adult patients with relapsed or refractory AML who have a specific genetic ...

AUGUST 2, 2017

Load more